Myometrial Thickness as a Predictor for the Latency Interval in PPROM
Sponsored by Cairo University
About this trial
Last updated 8 years ago
Study ID
Status
Type
Placebo
Accepting
Trial Timing
Ended 7 years ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
* singleton pregnancy with a definite history of current PPROM for the study group
Exclusion Criteria
* Suspected fetal growth restriction (IUGR),
* Any gross fetal anomalies,
* Abnormalities of placentation,
* Uterine structural abnormalities,
* Fetal jeopardy or intrauterine fetal death (IUFD).
* Women presenting with chorioamniointis with fever over 38 c abdominal tenderness, foul vaginal discharge and/or fetal tachycardia.
* Diabetics, immunocompromized and cardiac patients.
* Women with cervical cerclage.
* Women with drained liquor
